InVitro International, Inc. (IVRO)

InVitro International Financials Overview

Financials in millions USD. Fiscal year is October - September.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Revenue Revenue Growth	0.84	0.81	0.79	0.85	1	1.1
Revenue Growth	-15.90%	2.35%	-7.13%	-14.94%	-9.18%	4.95%
Gross Profit Gross Profit Growth	0.69	0.65	0.64	0.68	0.8	0.9
Operating Income Operating Income Growth	0.08	0.07	-0.03	-0.12	-0.03	0.03
Net Income Net Income Growth	0.12	0.11	0	0.02	0.1	0.05
Earnings Per Share EPS Growth	0.00	0.00	0.00	0.00	0.00	0.00
EPS Growth	0.03%	6053.85%	-93.07%	-76.54%	100.05%	-33.37%

Revenue by Geography

Chart

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
United States United States Growth	0.55	0.51	0.52	0.62	0.68	0.89
Other Countries Other Countries Growth	0.29	0.3	0.28	0.23	0.33	0.22
Total Total Growth	0.84	0.81	0.79	0.85	1	1.1

Cash & Debt

Chart

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Investments Cash & Investments Growth	1.27	1.27	1.17	1.23	1.31	1.16
Total Debt Total Debt Growth	0.33	0.34	0.04	-	0.1	0.11
Net Cash (Debt) Net Cash Growth	0.94	0.93	1.13	1.23	1.21	1.06
Net Cash Growth	-22.18%	-17.51%	-8.42%	2.24%	13.95%	-0.97%
Net Cash Per Share Net Cash Per Share Growth	0.04	0.04	0.05	0.05	0.05	0.05

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Operating Cash Flow Operating Cash Flow Growth	0.05	0.1	-0.06	0.04	0.03	-0.02
Capital Expenditures CapEx Growth	-	-	-0	-0.01	-0	-
Free Cash Flow Free Cash Flow Growth	0.05	0.1	-0.06	0.03	0.03	-0.02
Free Cash Flow Growth	59.81%	-	-	8.16%	-	-

Margins

Chart

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Gross Margin	81.72%	80.55%	80.24%	79.69%	80.15%	81.24%
Operating Margin	10.01%	8.42%	-3.20%	-13.68%	-2.67%	2.83%
Pretax Margin	14.66%	13.15%	0.30%	1.47%	10.51%	5.56%
Profit Margin	14.56%	13.15%	0.20%	2.49%	9.57%	4.52%
FCF Margin	5.47%	12.15%	-7.56%	3.66%	2.88%	-2.02%

Valuation

Chart

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 22, 2026	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
PE Ratio	15.00	21.24	838.98	69.53	40.31	50.18
P/FCF Ratio	28.93	22.98	-	47.34	133.92	-
PS Ratio	1.58	2.79	1.64	1.73	3.86	2.27

Data Source: S&P Global Market Intelligence Last updated: Oct 15, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error